Literature DB >> 17308924

Non-invasive assessment of vessel morphology and function in tumors by magnetic resonance imaging.

Fabian Kiessling1, Manfred Jugold, Eva C Woenne, Gunnar Brix.   

Abstract

The switch to an angiogenic phenotype is an important precondition for tumor growth, invasion and spread. Since newly formed vessels are characterized by structural, functional and molecular abnormalities, they offer promising targets for tumor diagnosis and therapy. Previous studies indicate that MRI is valuable to assess vessel morphology and function. It can be used to distinguish between benign and malignant lesions and to improve delineation of proliferating areas within heterogeneous tumors. In addition, tracer kinetic analysis of contrast-enhanced image series allows the estimation of well-defined physiological parameters such as blood volume, blood flow and vessel permeability. Frequently, changes of these parameters during cytostatic, anti-angiogenic and radiation therapy precede tumor volume reduction. Moreover, target-specific MRI techniques can be used to elucidate the expression of angiogenic markers at the molecular level. This review summarizes strategies for non-invasive characterization of tumor vascularization by functional and molecular MRI, hereby introducing representative preclinical and clinical applications.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17308924     DOI: 10.1007/s00330-006-0566-x

Source DB:  PubMed          Journal:  Eur Radiol        ISSN: 0938-7994            Impact factor:   7.034


  95 in total

1.  High-resolution MR venography of cerebral arteriovenous malformations.

Authors:  M Essig; J R Reichenbach; L R Schad; S O Schoenberg; J Debus; W A Kaiser
Journal:  Magn Reson Imaging       Date:  1999-12       Impact factor: 2.546

2.  Magnetic resonance contrast enhancement of neovasculature with alpha(v)beta(3)-targeted nanoparticles.

Authors:  S A Anderson; R K Rader; W F Westlin; C Null; D Jackson; G M Lanza; S A Wickline; J J Kotyk
Journal:  Magn Reson Med       Date:  2000-09       Impact factor: 4.668

Review 3.  Tumour microenvironment - opinion: validating matrix metalloproteinases as drug targets and anti-targets for cancer therapy.

Authors:  Christopher M Overall; Oded Kleifeld
Journal:  Nat Rev Cancer       Date:  2006-03       Impact factor: 60.716

4.  Anti-angiogenesis: new concept for therapy of solid tumors.

Authors:  J Folkman
Journal:  Ann Surg       Date:  1972-03       Impact factor: 12.969

5.  The antiangiogenic agent linomide inhibits the growth rate of von Hippel-Lindau paraganglioma xenografts to mice.

Authors:  D J Gross; I Reibstein; L Weiss; S Slavin; I Stein; M Neeman; R Abramovitch; L E Benjamin
Journal:  Clin Cancer Res       Date:  1999-11       Impact factor: 12.531

6.  Bone marrow microcirculation analysis in multiple myeloma by contrast-enhanced dynamic magnetic resonance imaging.

Authors:  T M Moehler; H Hawighorst; K Neben; G Egerer; J Hillengass; R Max; A Benner; A D Ho; G van Kaick; H Goldschmidt
Journal:  Int J Cancer       Date:  2001-09       Impact factor: 7.396

7.  Angiogenic activity of cervical carcinoma: assessment by functional magnetic resonance imaging-based parameters and a histomorphological approach in correlation with disease outcome.

Authors:  H Hawighorst; W Weikel; P G Knapstein; M V Knopp; I Zuna; S O Schönberg; P Vaupel; G van Kaick
Journal:  Clin Cancer Res       Date:  1998-10       Impact factor: 12.531

8.  In vivo assessment of tumoral angiogenesis.

Authors:  I Troprès; L Lamalle; M Péoc'h; R Farion; Y Usson; M Décorps; C Rémy
Journal:  Magn Reson Med       Date:  2004-03       Impact factor: 4.668

Review 9.  [Perfusion measurement using the T2* contrast media dynamics in neuro-oncology. Physical basics and clinical applications].

Authors:  M-A Weber; F Risse; F L Giesel; L R Schad; H-U Kauczor; M Essig
Journal:  Radiologe       Date:  2005-07       Impact factor: 0.635

10.  Can pre-operative contrast-enhanced dynamic MR imaging for prostate cancer predict microvessel density in prostatectomy specimens?

Authors:  Heinz-Peter Schlemmer; Jonas Merkle; Rainer Grobholz; Tim Jaeger; Maurice Stephan Michel; Axel Werner; Jan Rabe; Gerhard van Kaick
Journal:  Eur Radiol       Date:  2003-10-03       Impact factor: 5.315

View more
  16 in total

Review 1.  Tracer kinetic modelling of tumour angiogenesis based on dynamic contrast-enhanced CT and MRI measurements.

Authors:  Gunnar Brix; Jürgen Griebel; Fabian Kiessling; Frederik Wenz
Journal:  Eur J Nucl Med Mol Imaging       Date:  2010-08       Impact factor: 9.236

2.  [Modern magnetic resonance procedures for assessing tumor response].

Authors:  T Persigehl; W Heindel; C Bremer
Journal:  Radiologe       Date:  2008-09       Impact factor: 0.635

3.  Imaging techniques as predictive and prognostic biomarkers in renal cell carcinoma.

Authors:  Paul Nathan; Anup Vinayan
Journal:  Ther Adv Med Oncol       Date:  2013-03       Impact factor: 8.168

4.  [Dynamic contrast-enhanced computed tomography. Tracer kinetics and radiation hygienic principles].

Authors:  G Brix; J Griebel; S Delorme
Journal:  Radiologe       Date:  2012-03       Impact factor: 0.635

5.  Evaluation of cancer treatment in the abdomen: Trends and advances.

Authors:  Silanath Peungjesada; Hubert H Chuang; Srinivasa R Prasad; Haesun Choi; Evelyne M Loyer; Yulia Bronstein
Journal:  World J Radiol       Date:  2013-03-28

6.  Bevacizumab inhibits breast cancer-induced osteolysis, surrounding soft tissue metastasis, and angiogenesis in rats as visualized by VCT and MRI.

Authors:  Tobias Bäuerle; Heidegard Hilbig; Sönke Bartling; Fabian Kiessling; Astrid Kersten; Annette Schmitt-Gräff; Hans-Ulrich Kauczor; Stefan Delorme; Martin R Berger
Journal:  Neoplasia       Date:  2008-05       Impact factor: 5.715

Review 7.  [Cellular mechanisms of tumor response: clinical demands].

Authors:  M-K Ganten; M A Weber; T M Ganten
Journal:  Radiologe       Date:  2008-09       Impact factor: 0.635

Review 8.  Imaging response to systemic therapy for bone metastases.

Authors:  Tobias Bäuerle; Wolfhard Semmler
Journal:  Eur Radiol       Date:  2009-05-26       Impact factor: 5.315

9.  Enhanced antitumor efficacy of a vascular disrupting agent combined with an antiangiogenic in a rat liver tumor model evaluated by multiparametric MRI.

Authors:  Feng Chen; Yingmei Feng; Kaier Zheng; Frederik De Keyzer; Junjie Li; Yuanbo Feng; Marlein Miranda Cona; Huaijun Wang; Yansheng Jiang; Jie Yu; Guy Marchal; Catherine Verfaillie; Bart De Geest; Raymond Oyen; Yicheng Ni
Journal:  PLoS One       Date:  2012-07-18       Impact factor: 3.240

10.  Non-invasive imaging for studying anti-angiogenic therapy effects.

Authors:  Josef Ehling; Twan Lammers; Fabian Kiessling
Journal:  Thromb Haemost       Date:  2013-02-14       Impact factor: 5.249

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.